×
Entrez Id:
6352
Gene Symbol:
CCL5
CCL5
Asthma
0.600
Biomarker
RGD
Role of the extracellular signal-regulated kinase 1/2 signaling pathway in regulating the secretion of bronchial smooth muscle cells in a rat model of chronic asthma.
18208670
2008
×
Entrez Id:
6352
Gene Symbol:
CCL5
CCL5
Hyperoxaluria
0.500
Biomarker
RGD
NF-kappaB and chemokine-cytokine expression in renal tubulointerstitium in experimental hyperoxaluria. Role of the renin-angiotensin system.
16284884
2005
×
Entrez Id:
6352
Gene Symbol:
CCL5
CCL5
Arteriosclerosis
0.290
Biomarker
RGD
Dietary fatty acid unsaturation levels, lipoprotein oxidation and circulating chemokine in experimentally induced atherosclerotic rats.
16259780
2005
×
Entrez Id:
6352
Gene Symbol:
CCL5
CCL5
Endometriosis
0.280
Biomarker
RGD
Cytokine and chemokine expression in a rat endometriosis is similar to that in human endometriosis.
18595729
2008
×
Entrez Id:
6352
Gene Symbol:
CCL5
CCL5
Myocardial Infarction
0.240
Biomarker
RGD
CCR3- and CXCR4-mediated interactions regulate migration of CD34+ human bone marrow progenitors to ischemic myocardium and subsequent tissue repair.
18954648
2008
×
Entrez Id:
6352
Gene Symbol:
CCL5
CCL5
Obesity
0.240
Biomarker
RGD
RANTES and MCP-1 serum levels were increased in obese vs lean Zucker rats and significantly reduced by long-term treatment with rimonabant, which slowed weight gain in rats with the metabolic syndrome.
18469848
2008
×
Entrez Id:
6352
Gene Symbol:
CCL5
CCL5
Kidney Failure, Chronic
0.220
Biomarker
RGD
Role of FTY720 on M1 and M2 macrophages, lymphocytes, and chemokines in 5/6 nephrectomized rats.
19535570
2009
×
Entrez Id:
6352
Gene Symbol:
CCL5
CCL5
Chronic kidney disease stage 5
0.220
Biomarker
RGD
Role of FTY720 on M1 and M2 macrophages, lymphocytes, and chemokines in 5/6 nephrectomized rats.
19535570
2009
×
Entrez Id:
6352
Gene Symbol:
CCL5
CCL5
Hyperalgesia
0.220
Biomarker
RGD
Pretreatment with antibodies against RANTES /CCL5 prevented the hyperalgesic response, indicating that RANTES /CCL5 is able to interfere with the control of hyperalgesia at the level of the periaqueductal grey and suggesting that chemokine blockers could have analgesic properties.
18656466
2008
×
Entrez Id:
6352
Gene Symbol:
CCL5
CCL5
Hyperalgesia
0.220
Biomarker
RGD
Delayed functional expression of neuronal chemokine receptors following focal nerve demyelination in the rat: a mechanism for the development of chronic sensitization of peripheral nociceptors.
18076762
2007
×
Entrez Id:
6352
Gene Symbol:
CCL5
CCL5
Inflammation
0.220
Biomarker
RGD
In our study, we established the involvement of RANTES in an in vivo model of chronic inflammation induced by potassium permanganate, leading to calcified granulomas.
17164972
2007
×
Entrez Id:
6352
Gene Symbol:
CCL5
CCL5
Kidney Diseases
0.220
Biomarker
RGD
DNA vaccination with naked DNA encoding MCP-1 and RANTES protects against renal injury in adriamycin nephropathy.
15882261
2005
×
Entrez Id:
6352
Gene Symbol:
CCL5
CCL5
×
CUI:
C0030193
Disease:
Pain
Pain
0.220
Biomarker
RGD
Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons.
11438578
2001
×
Entrez Id:
6352
Gene Symbol:
CCL5
CCL5
Cardiac Arrest
0.210
Biomarker
RGD
Minocycline reduces neuronal death and attenuates microglial response after pediatric asphyxial cardiac arrest.
19756023
2010
×
Entrez Id:
6352
Gene Symbol:
CCL5
CCL5
Metabolic Syndrome X
0.210
Biomarker
RGD
Impact of chronic anticholesterol therapy on development of microvascular rarefaction in the metabolic syndrome.
19905967
2009
×
Entrez Id:
6352
Gene Symbol:
CCL5
CCL5
Uveitis
0.210
Biomarker
RGD
Th1- and Th2-related chemokine and chemokine receptor expression on the ocular surface in endotoxin-induced uveitis.
19104678
2008
×
Entrez Id:
6352
Gene Symbol:
CCL5
CCL5
Pancreatitis
0.210
Biomarker
RGD
Bile-pancreatic juice exclusion promotes Akt/NF-kappaB activation and chemokine production in ligation-induced acute pancreatitis.
16843865
2006
×
Entrez Id:
6352
Gene Symbol:
CCL5
CCL5
Acute alcoholic liver disease
0.200
Therapeutic
RGD
Optimal ratio of 18α- and 18β-glycyrrhizic acid for preventing alcoholic hepatitis in rats.
31258651
2019
×
Entrez Id:
6352
Gene Symbol:
CCL5
CCL5
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Therapeutic
RGD
Steatosis induced CCL5 contributes to early-stage liver fibrosis in nonalcoholic fatty liver disease progress.
27639593
2017
×
Entrez Id:
6352
Gene Symbol:
CCL5
CCL5
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
ModifyingMutation
RGD
Steatosis induced CCL5 contributes to early-stage liver fibrosis in nonalcoholic fatty liver disease progress.
27639593
2017
×
Entrez Id:
6352
Gene Symbol:
CCL5
CCL5
LIVER DISEASE, ALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
Therapeutic
RGD
Steatosis induced CCL5 contributes to early-stage liver fibrosis in nonalcoholic fatty liver disease progress.
27639593
2017
×
Entrez Id:
6352
Gene Symbol:
CCL5
CCL5
LIVER DISEASE, ALCOHOLIC, SUSCEPTIBILITY TO, 1
0.200
ModifyingMutation
RGD
Steatosis induced CCL5 contributes to early-stage liver fibrosis in nonalcoholic fatty liver disease progress.
27639593
2017
×
Entrez Id:
6352
Gene Symbol:
CCL5
CCL5
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 2
0.200
ModifyingMutation
RGD
Steatosis induced CCL5 contributes to early-stage liver fibrosis in nonalcoholic fatty liver disease progress.
27639593
2017
×
Entrez Id:
6352
Gene Symbol:
CCL5
CCL5
FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 2
0.200
Therapeutic
RGD
Steatosis induced CCL5 contributes to early-stage liver fibrosis in nonalcoholic fatty liver disease progress.
27639593
2017
×
Entrez Id:
6352
Gene Symbol:
CCL5
CCL5
Visual seizure
0.200
Biomarker
RGD
Role of CCR5 and its ligands in the control of vascular inflammation and leukocyte recruitment required for acute excitotoxic seizure induction and neural damage.
20940264
2011